PHR / Phreesia, Inc. (PHR) CEO Chaim Indig on Q4 2022 Results - Earnings Call Transcript

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions more_horizontal

While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended July 2023, it could be worth more_horizontal

Phreesia, Inc. (NYSE:PHR ) Q2 2024 Earnings Conference Call September 6, 2023 5:00 PM ET Company Participants Chaim Indig - Chief Executive Officer Ba more_horizontal

Phreesia (PHR) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.8 more_horizontal

Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

The consensus price target hints at a 27.3% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardl more_horizontal

Phreesia, Inc. provides a suite of patient care software and services to healthcare providers in the U.S. and Canada. Management recently guided to sl more_horizontal

I reiterate a buy rating for PHR due to its strong execution and consistent addition of new logos, despite the uncertain environment. PHR's conservati more_horizontal